Description

(5-Methyl-5,6,7,8-Tetrahydro-Benzo[4,5]Thieno[2,3-D]Pyrimidin-4-Ylamino)-Acetic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value in medicinal chemistry for the research and development of novel therapeutic agents, particularly kinase inhibitors. It is primarily sought after by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of targeted small-molecule drugs. The material's specific molecular architecture makes it a critical building block for creating compounds with potential activity in oncology and other disease areas.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel kinase inhibitors and other targeted small-molecule therapeutics.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies during drug discovery programs.
• Biochemical Research: Serves as a reference standard or probe compound in enzymatic assays and biological target validation.
• Fine Chemical Synthesis: Employed in multi-step organic syntheses to construct complex molecular frameworks for specialized applications.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations providing custom synthesis and process development services for the pharmaceutical industry.

Basic Information

Product Name	(5-Methyl-5,6,7,8-Tetrahydro-Benzo[4,5]Thieno[2,3-D]Pyrimidin-4-Ylamino)-Acetic Acid
CAS No.	886498-95-9
Molecular Formula	C₁₅H₁₇N₃O₂S
Molecular Weight	303.38 g/mol
Synonyms	4-[(Amino)(5-methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]acetic acid; 2-[(5-Methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-yl)amino]acetic acid; (5-Methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-ylamino)acetic acid; 886498-95-9; 5-Methyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-ylamino-acetic acid
EINECS	Contact for details

Quality Control

Our production of (5-Methyl-5,6,7,8-Tetrahydro-Benzo[4,5]Thieno[2,3-D]Pyrimidin-4-Ylamino)-Acetic Acid adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the exacting standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing all specifications and test results are provided and can be tailored to meet specific client or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). Due to its hygroscopic nature, the container should be kept in a desiccated environment. Handle and store under an inert atmosphere for long-term stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.